Santori & Peters Inc’s Idexx Laboratories IDXX Stock Holding History

Santori & Peters Inc’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6	Closed	-$1K	–	284
2017 Q4	$1K	Buy	+6	New	+$944	﹤0.01%	597

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Santori & Peters Inc's IDXX Position: Q1 2018 in Review

Santori & Peters Inc sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 6 shares — an estimated $1K sold.

Santori & Peters Inc first reported a position in IDXX in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 645 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

Santori & Peters Inc reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 6 Idexx Laboratories shares in Q1 2018, an estimated $1K.
Santori & Peters Inc first reported a position in Idexx Laboratories in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's Idexx Laboratories position peaked at $1K in Q4 2017.
645 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.